Sterne Agee Starts Actavis (ACT) at Buy
Tweet
Share
E-mailGet Alerts ACT Hot Sheet
Price: $49.46 +0.32%
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
Sterne Agee initiated coverage on Actavis (NYSE: ACT) with a Buy rating and a price target of $230.00.
For an analyst ratings summary and ratings history on Actavis click here. For more ratings news on Actavis click here.
Shares of Actavis closed at $193.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'
- Nomura/Instinet Resumes Kobe Bussan Co Ltd (3038:JP) at Neutral
- TD Cowen Starts Faeth Therapeutics (FTH) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Sterne AgeeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
